Traumatic Brain Injury (TBI) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032


 Traumatic Brain Injury (TBI) is a disruption in the brain's normal functioning caused by physical impact to the head, such as a blow, bump, or jolt, or when an object penetrates the skull and enters the brain tissue. Clinical signs indicating an alteration in normal brain function include loss of consciousness or decreased consciousness, memory loss (amnesia) for events before or after the injury, focal neurological deficits like muscle weakness or loss of vision, and changes in mental state such as disorientation or difficulty concentrating. The frontal and temporal areas of the brain are primarily affected. Mild TBI, also known as brain concussion, has gained significant attention due to its potential adverse neuropsychological outcomes in civilian populations (e.g., athletes in contact sports) and military personnel. Moderate to severe TBI is a major cause of injury-related death and disability. TBI symptoms can range from mild to severe, depending on the extent of brain damage. Mild cases may temporarily alter mental state or consciousness, while severe cases can lead to prolonged unconsciousness, coma, or even death. There are two main types of head injuries: Penetrating TBI, which occurs when an object pierces the skull and damages a specific area of the brain, and non-penetrating TBI, caused by a strong external force that moves the brain within the skull. Causes of non-penetrating TBI include falls, motor vehicle accidents, sports injuries, blast injuries, and being struck by an object. Clinical features of TBI may include prolonged coma, headache, nausea, aphasia (language difficulties), seizures, amnesia, and behavioral abnormalities such as aggression and anxiety. These symptoms can occur within seconds to minutes after the injury and may persist for months or years. The severity of TBI is evaluated using measures such as level of consciousness (LOC), altered mental status (AMS), post-traumatic amnesia (PTA), and the Glasgow Coma Scale (GCS). TBI causes damage to neuronal tissues, which can be classified into two categories: primary injury, directly caused by the mechanical forces during the initial insult, and secondary injury, which refers to further tissue and cellular damage after the primary insult. The differential diagnosis for TBI includes stroke, spontaneous acute subdural hematoma, Alzheimer's disease, cerebral aneurysms, frontal lobe syndrome, and hydrocephalus.

·       TBI is a significant cause of death and disability among children and young adults in the United States. It is estimated that 1.5 million Americans sustain a TBI yearly, resulting in approximately 230,000 hospitalizations, 50,000 deaths, and 80,000 to 90,000 cases of long-term disability.

Thelansis’s “Traumatic Brain Injury (TBI) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Traumatic Brain Injury (TBI) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Traumatic Brain Injury (TBI) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Traumatic Brain Injury (TBI) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Traumatic Brain Injury (TBI) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Herpes Simplex Virus (HSV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Herpes simplex virus (HSV) causes an infection that affects the external genitalia, anal region, mucosal surfaces, and skin in other body parts. Herpes simplex virus is a ubiquitous, host-adapted pathogen that causes various disease states. There are two types of HSV with two distinct DNA viruses, type 1 (HSV-1) and type 2 (HSV-2). Both the types are closely related but differ epidemiologically. HSV-1 is traditionally associated with orofacial disease by affecting the mouth and lips with fever blisters and cold sores, whereas HSV-2 is associated traditionally with genital disease infecting genitals and rectum area with sores and is classified as STD (sexually transmitted disease). As HSV-1 is associated with genital infections more often than HSV-2, lesion location is not necessarily of viral type. HSV can spread through direct contact. Almost 80% of Herpes simplex infections are asymptomatic, while symptomatic infections can be characterized by significant morbidity and recurrenc...
Read more

HR+/HER2- Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
Thelansis’s “HR+/HER2- Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HR+/HER2- Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of HR+/HER2- Breast Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. HR+/HER2- Breast Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model,...
Read more